| pubmed-article:11312372 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11312372 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11312372 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
| pubmed-article:11312372 | lifeskim:mentions | umls-concept:C0150887 | lld:lifeskim |
| pubmed-article:11312372 | lifeskim:mentions | umls-concept:C0024432 | lld:lifeskim |
| pubmed-article:11312372 | lifeskim:mentions | umls-concept:C0544452 | lld:lifeskim |
| pubmed-article:11312372 | lifeskim:mentions | umls-concept:C0301630 | lld:lifeskim |
| pubmed-article:11312372 | lifeskim:mentions | umls-concept:C1880022 | lld:lifeskim |
| pubmed-article:11312372 | lifeskim:mentions | umls-concept:C1550605 | lld:lifeskim |
| pubmed-article:11312372 | lifeskim:mentions | umls-concept:C0456205 | lld:lifeskim |
| pubmed-article:11312372 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:11312372 | pubmed:dateCreated | 2001-4-20 | lld:pubmed |
| pubmed-article:11312372 | pubmed:abstractText | To document the change in synovial membrane macrophage and T-lymphocyte content in rheumatoid arthritis (RA) patients who achieve remission induced by disease-modifying anti-rheumatic drugs (DMARDs). | lld:pubmed |
| pubmed-article:11312372 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11312372 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11312372 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11312372 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11312372 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11312372 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:11312372 | pubmed:issn | 1462-0324 | lld:pubmed |
| pubmed-article:11312372 | pubmed:author | pubmed-author:SmithM DMD | lld:pubmed |
| pubmed-article:11312372 | pubmed:author | pubmed-author:ColemanMM | lld:pubmed |
| pubmed-article:11312372 | pubmed:author | pubmed-author:BOOO | lld:pubmed |
| pubmed-article:11312372 | pubmed:author | pubmed-author:Roberts-Thoms... | lld:pubmed |
| pubmed-article:11312372 | pubmed:author | pubmed-author:AhernM JMJ | lld:pubmed |
| pubmed-article:11312372 | pubmed:author | pubmed-author:ParkerAA | lld:pubmed |
| pubmed-article:11312372 | pubmed:author | pubmed-author:WeedonHH | lld:pubmed |
| pubmed-article:11312372 | pubmed:author | pubmed-author:SlavotinekJJ | lld:pubmed |
| pubmed-article:11312372 | pubmed:author | pubmed-author:KraanM CMC | lld:pubmed |
| pubmed-article:11312372 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11312372 | pubmed:volume | 40 | lld:pubmed |
| pubmed-article:11312372 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11312372 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11312372 | pubmed:pagination | 367-74 | lld:pubmed |
| pubmed-article:11312372 | pubmed:dateRevised | 2007-9-6 | lld:pubmed |
| pubmed-article:11312372 | pubmed:meshHeading | pubmed-meshheading:11312372... | lld:pubmed |
| pubmed-article:11312372 | pubmed:meshHeading | pubmed-meshheading:11312372... | lld:pubmed |
| pubmed-article:11312372 | pubmed:meshHeading | pubmed-meshheading:11312372... | lld:pubmed |
| pubmed-article:11312372 | pubmed:meshHeading | pubmed-meshheading:11312372... | lld:pubmed |
| pubmed-article:11312372 | pubmed:meshHeading | pubmed-meshheading:11312372... | lld:pubmed |
| pubmed-article:11312372 | pubmed:meshHeading | pubmed-meshheading:11312372... | lld:pubmed |
| pubmed-article:11312372 | pubmed:meshHeading | pubmed-meshheading:11312372... | lld:pubmed |
| pubmed-article:11312372 | pubmed:meshHeading | pubmed-meshheading:11312372... | lld:pubmed |
| pubmed-article:11312372 | pubmed:meshHeading | pubmed-meshheading:11312372... | lld:pubmed |
| pubmed-article:11312372 | pubmed:meshHeading | pubmed-meshheading:11312372... | lld:pubmed |
| pubmed-article:11312372 | pubmed:meshHeading | pubmed-meshheading:11312372... | lld:pubmed |
| pubmed-article:11312372 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11312372 | pubmed:articleTitle | Treatment-induced remission in rheumatoid arthritis patients is characterized by a reduction in macrophage content of synovial biopsies. | lld:pubmed |
| pubmed-article:11312372 | pubmed:affiliation | Department of Medicine, Flinders Medical Centre, Adelaide, South Australia. | lld:pubmed |
| pubmed-article:11312372 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11312372 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11312372 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11312372 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11312372 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11312372 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11312372 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11312372 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11312372 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11312372 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11312372 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11312372 | lld:pubmed |
